Samina Naseer, MD
Family Medicine · Pittsburgh, PANPI 1245406149
Payments from drug & device makers
Across 267 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$980
- AbbVie$666
- Lilly USA, LLC$411
- Amgen$316
- Novo Nordisk$260
- Bayer$240
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,049100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 57 | $980 |
| AbbVie | 32 | $666 |
| Lilly USA, LLC | 24 | $411 |
| Amgen | 19 | $316 |
| Novo Nordisk | 14 | $260 |
| Bayer | 12 | $240 |
| Organogenesis Inc. | 6 | $220 |
| Smith+Nephew | 9 | $184 |
| Johnson & Johnson | 11 | $178 |
| Astellas Pharma US Inc | 8 | $169 |
| Boehringer Ingelheim | 10 | $150 |
| Sanofi-aventis U.S. LLC | 7 | $142 |
| Pfizer | 5 | $121 |
| Idorsia Pharmaceuticals US Inc | 6 | $112 |
| AstraZeneca | 6 | $90 |
| Corcept Therapeutics | 3 | $89 |
| Lifenet Health | 1 | $65 |
| Merck | 4 | $58 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| Integra Lifesciences Corporation | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Tactile Systems Technology Inc | 3 | $46 |
| Abiomed | 2 | $44 |
| Kerecis Limited | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Urgo Medical North America, LLC | 1 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Cumberland Pharmaceuticals, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| KCI USA, Inc. | 1 | $26 |
| Solventum Corporation | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $23 |
| Bsn Medical Inc | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $18 |
| Misonix Inc | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| Biogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$122
How this compares
$5,061 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $43,955 |
| OzempicSemaglutide | 38 | $34,795 |
| XareltoRivaroxaban | 48 | $27,245 |
| EliquisApixaban | 35 | $25,764 |
| JardianceEmpagliflozin | 35 | $25,061 |
| SantylCollagenase Clostridium Hist. | 13 | $14,517 |
| TradjentaLinagliptin | 12 | $12,024 |
| Atorvastatin Calcium | 384 | $4,265 |
| CymbaltaDuloxetine Hcl | 11 | $2,862 |
| Potassium Chloride | 71 | $2,727 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $2,699 |
| Metoprolol Succinate | 114 | $2,004 |
| Losartan Potassium | 175 | $1,894 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,839 |
| Levothyroxine Sodium | 129 | $1,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $980 | $43,95557 claims |
| Boehringer IngelheimJardiance, Tradjenta | $150 | $37,08447 claims |
| Novo NordiskOzempic | $260 | $34,79538 claims |
| Johnson & JohnsonXarelto | $178 | $27,24548 claims |
| PfizerEliquis | $121 | $25,76435 claims |
| Smith+NephewSantyl | $184 | $14,51713 claims |
| Lilly USA, LLCCymbalta | $411 | $2,86211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Pittsburgh
- Bryce PalchickPittsburgh$4.7M
- Shari RozenPittsburgh$2.9M
- Nathan BennettPittsburgh$1.6M
- James MorettiPittsburgh$1.5M
- Michael GatesPittsburgh$608K
- Daniel AustinPittsburgh$598K
- Norman KolbPittsburgh$81K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.